美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Propanc Biopharma, Inc.

3.99

-1.5100-27.45%

成交量：271.00

成交額：1,072.13

市值：4,633.11萬

市盈率：-14.74

高：3.99

開：3.99

低：3.99

收：5.50

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Propanc Biopharma, Inc.

交易所：

PINK

成立時間：

2007

員工人數：

2

公司地址：

302, 6 Butler Street,Camberwell,Victoria,Australia

官網：

http://www.propanc.com

郵編：

3124

電話：

傳真：

61 3 9882 9969

簡介：

Propanc Biopharma, Inc.最初於2007年10月15日在澳大利亞維多利亞州墨爾本成立。2010年11月23日，該公司在特拉華州重新註冊並重新註冊。他們是一家發展階段的醫療保健公司，目前專註於為患有胰腺癌、卵巢癌和癌症的患者開發新的癌症治療方法。利用他們的科學和腫瘤學顧問，他們開發了一種合理的抗癌化合物複合配方，這些化合物共同發揮多種作用，旨在控制或防止腫瘤在體內複發和擴散。他們的主要候選產品PRP是他們新配方的變體，涉及酶原，即酶的無活性前體。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PPCB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPCB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":3.99,"timestamp":1745601516166,"preClose":5.5,"halted":0,"volume":271,"delay":15,"floatShares":11611800,"shares":11611800,"eps":-0.270622,"marketStatus":"交易中","change":-1.51,"latestTime":"04-25 13:18:36 EDT 延時","open":3.99,"high":3.99,"low":3.99,"amount":1072.1260000000002,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.270622,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1745611200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":5.5,"volumeRatio":0.228552},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","floatShares":11611800,"roa":"-462.23%","roe":"1.09%","lyrEps":-1.798272,"volumeRatio":0.228552,"shares":11611800,"dividePrice":0,"high":3.99,"amplitude":0,"preClose":5.5,"low":3.99,"week52Low":0.0002,"pbRate":"-11.14","week52High":222,"institutionHeld":0,"latestPrice":3.99,"eps":-0.270622,"divideRate":0,"volume":271,"delay":15,"ttmEps":-0.270622,"open":3.99,"prevYearClose":0.0002,"prevWeekClose":8,"prevMonthClose":5.5,"prevQuarterClose":5.5,"fiveDayClose":8,"twentyDayClose":5.68,"sixtyDayClose":0.0002},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":134729532,"yearFounded":2007,"employeeNum":2,"address":"302, 6 Butler Street,Camberwell,Victoria,Australia","zipCode":"3124","officePhone":"61 3 9882 0780","officeFax":"61 3 9882 9969"},"stockCompanyDetail":{"websiteUrl":"http://www.propanc.com","stockEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.1942},{"period":"3month","weight":121.0588},{"period":"6month","weight":82},{"period":"1year","weight":9.7792},{"period":"ytd","weight":42.0052}],"description":"Propanc Biopharma, Inc.最初於2007年10月15日在澳大利亞維多利亞州墨爾本成立。2010年11月23日，該公司在特拉華州重新註冊並重新註冊。他們是一家發展階段的醫療保健公司，目前專註於為患有胰腺癌、卵巢癌和癌症的患者開發新的癌症治療方法。利用他們的科學和腫瘤學顧問，他們開發了一種合理的抗癌化合物複合配方，這些化合物共同發揮多種作用，旨在控制或防止腫瘤在體內複發和擴散。他們的主要候選產品PRP是他們新配方的變體，涉及酶原，即酶的無活性前體。","exchange":"PINK","name":"Propanc Biopharma, Inc.","nameEN":"Propanc Biopharma, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPCB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-29","symbol":"PPCB","defaultRemindTime":1738161000000,"type":"split","dateTimestamp":1738126800000,"forFactor":60000,"toFactor":1,"ratio":60000},{"market":"US","date":"2023-05-23","symbol":"PPCB","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2020-11-19","symbol":"PPCB","defaultRemindTime":1605796200000,"type":"split","dateTimestamp":1605762000000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2019-06-24","symbol":"PPCB","type":"split","dateTimestamp":1561348800000,"forFactor":500,"toFactor":1,"ratio":500}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPCB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PPCB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PPCB","date":"2025-04-07","current":-0.048332,"percent":1,"low":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"high":-0.048332,"avg":-0.050058,"sd":0.000996,"marketCap":80703},"quantilePoints":[{"date":"2025-04-04","current":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.050633,"marketCap":84546},{"date":"2025-04-07","current":-0.048332,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"marketCap":80703}],"updateTime":1745596734001}}}